**Core Concept**
Chronic progressive external ophthalmoplegia (CPEO) is a mitochondrial myopathy characterized by progressive weakness and external ophthalmoplegia. It is often associated with Kearns-Sayre syndrome and other mitochondrial disorders. The condition is caused by mutations in mitochondrial DNA, leading to impaired energy production in muscle cells.

**Why the Correct Answer is Right**
The correct answer is a feature that is not typically associated with CPEO. CPEO is characterized by external ophthalmoplegia, which is the inability to move the eyes in all directions due to weakness of the extraocular muscles. This is often accompanied by ptosis (drooping eyelids) and other systemic features such as heart block, hearing loss, and pigmentary retinopathy. The correct answer is not a feature of CPEO because it does not align with the typical clinical presentation of the condition.

**Why Each Wrong Option is Incorrect**
**Option A:** External ophthalmoplegia is a hallmark feature of CPEO, making this option incorrect.
**Option B:** Ptosis is a common feature of CPEO, often presenting as drooping eyelids. This option is incorrect.
**Option C:** Cardiac conduction defects, such as heart block, are a common feature of Kearns-Sayre syndrome, which is often associated with CPEO. This option is incorrect.

**Clinical Pearl / High-Yield Fact**
CPEO is a mitochondrial myopathy that often presents with external ophthalmoplegia, ptosis, and other systemic features. It is essential to consider this condition in patients with progressive external ophthalmoplegia, especially if they have other systemic symptoms.

**Correct Answer: C. Cardiac conduction defects are not typically associated with CPEO, although they can occur in Kearns-Sayre syndrome, which is a related condition.**